These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 21835849)

  • 1. Cancer targeting gene-viro-therapy specific for liver cancer by α-fetoprotein-controlled oncolytic adenovirus expression of SOCS3 and IL-24.
    Cao X; Wei R; Liu X; Zeng Y; Huang H; Ding M; Zhang K; Liu XY
    Acta Biochim Biophys Sin (Shanghai); 2011 Oct; 43(10):813-21. PubMed ID: 21835849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Augmenting the antitumor effect of TRAIL by SOCS3 with double-regulated replicating oncolytic adenovirus in hepatocellular carcinoma.
    Wei RC; Cao X; Gui JH; Zhou XM; Zhong D; Yan QL; Huang WD; Qian QJ; Zhao FL; Liu XY
    Hum Gene Ther; 2011 Sep; 22(9):1109-19. PubMed ID: 21361790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complete eradication of hepatomas using an oncolytic adenovirus containing AFP promoter controlling E1A and an E1B deletion to drive IL-24 expression.
    Zhang KJ; Zhang J; Wu YM; Qian J; Liu XJ; Yan LC; Zhou XM; Xiao RJ; Wang YG; Cao X; Wei N; Liu XR; Tang B; Jiao XY; Chen K; Liu XY
    Cancer Gene Ther; 2012 Sep; 19(9):619-29. PubMed ID: 22790965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer targeting Gene-Viro-Therapy of liver carcinoma by dual-regulated oncolytic adenovirus armed with TRAIL gene.
    Cao X; Yang M; Wei RC; Zeng Y; Gu JF; Huang WD; Yang DQ; Li HL; Ding M; Wei N; Zhang KJ; Xu B; Liu XR; Qian QJ; Liu XY
    Gene Ther; 2011 Aug; 18(8):765-77. PubMed ID: 21412282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene-viro-therapy targeting liver cancer by a dual-regulated oncolytic adenoviral vector harboring IL-24 and TRAIL.
    Liu X; Cao X; Wei R; Cai Y; Li H; Gui J; Zhong D; Liu XY; Huang K
    Cancer Gene Ther; 2012 Jan; 19(1):49-57. PubMed ID: 21979578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HCCS1-armed, quadruple-regulated oncolytic adenovirus specific for liver cancer as a cancer targeting gene-viro-therapy strategy.
    Xu HN; Huang WD; Cai Y; Ding M; Gu JF; Wei N; Sun LY; Cao X; Li HG; Zhang KJ; Liu XR; Liu XY
    Mol Cancer; 2011 Nov; 10():133. PubMed ID: 22040050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transfer of suppressor of cytokine signaling 3 by an oncolytic adenovirus induces potential antitumor activities in hepatocellular carcinoma.
    Cui Q; Jiang W; Wang Y; Lv C; Luo J; Zhang W; Lin F; Yin Y; Cai R; Wei P; Qian C
    Hepatology; 2008 Jan; 47(1):105-12. PubMed ID: 17935223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antitumor efficacy of IL-24 mediated by E1A and E1B triple regulated oncolytic adenovirus.
    Xiao LL; Wu YM; Qian J; Tan Y; Xie GL; Zhang KJ; Wang YG; Jia XY; Liu XY
    Cancer Biol Ther; 2010 Aug; 10(3):242-50. PubMed ID: 20574150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene therapy targeting hepatocellular carcinoma by a dual-regulated oncolytic adenovirus harboring the focal adhesion kinase shRNA.
    Gao Y; Zhu Y; Huang X; Ai K; Zheng Q; Yuan Z
    Int J Oncol; 2015 Aug; 47(2):668-78. PubMed ID: 26081241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate cancer-specific and potent antitumor effect of a DD3-controlled oncolytic virus harboring the PTEN gene.
    Ding M; Cao X; Xu HN; Fan JK; Huang HL; Yang DQ; Li YH; Wang J; Li R; Liu XY
    PLoS One; 2012; 7(4):e35153. PubMed ID: 22509396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined therapy with oncolytic adenoviruses encoding TRAIL and IL-12 genes markedly suppressed human hepatocellular carcinoma both in vitro and in an orthotopic transplanted mouse model.
    El-Shemi AG; Ashshi AM; Na Y; Li Y; Basalamah M; Al-Allaf FA; Oh E; Jung BK; Yun CO
    J Exp Clin Cancer Res; 2016 May; 35():74. PubMed ID: 27154307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new oncolytic adenoviral vector carrying dual tumour suppressor genes shows potent anti-tumour effect.
    Liu XR; Cai Y; Cao X; Wei RC; Li HL; Zhou XM; Zhang KJ; Wu S; Qian QJ; Cheng B; Huang K; Liu XY
    J Cell Mol Med; 2012 Jun; 16(6):1298-309. PubMed ID: 21794078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel oncolytic adenovirus targeting Wnt signaling effectively inhibits cancer-stem like cell growth via metastasis, apoptosis and autophagy in HCC models.
    Zhang J; Lai W; Li Q; Yu Y; Jin J; Guo W; Zhou X; Liu X; Wang Y
    Biochem Biophys Res Commun; 2017 Sep; 491(2):469-477. PubMed ID: 28698142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting gene-virus-mediated manganese superoxide dismutase effectively suppresses tumor growth in hepatocellular carcinoma in vitro and in vivo.
    Huang F; Ma B; Wang Y; Xiao R; Kong Y; Zhou X; Xia D
    Cancer Biother Radiopharm; 2014 Dec; 29(10):403-11. PubMed ID: 25414976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent antitumor activity of oncolytic adenovirus expressing mda-7/IL-24 for colorectal cancer.
    Zhao L; Gu J; Dong A; Zhang Y; Zhong L; He L; Wang Y; Zhang J; Zhang Z; Huiwang J; Qian Q; Qian C; Liu X
    Hum Gene Ther; 2005 Jul; 16(7):845-58. PubMed ID: 16000066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of tumor suppressor TSLC1 by a survivin-regulated oncolytic adenovirus significantly inhibits hepatocellular carcinoma growth.
    He G; Lei W; Wang S; Xiao R; Guo K; Xia Y; Zhou X; Zhang K; Liu X; Wang Y
    J Cancer Res Clin Oncol; 2012 Apr; 138(4):657-70. PubMed ID: 22237452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategy of Cancer Targeting Gene-Viro-Therapy (CTGVT) a trend in both cancer gene therapy and cancer virotherapy.
    Liu XY; Li HG; Zhang KJ; Gu JF
    Curr Pharm Biotechnol; 2012 Jul; 13(9):1761-7. PubMed ID: 21740358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-α enhances antitumor activities of oncolytic adenovirus-mediated IL-24 expression in hepatocellular carcinoma.
    Wang CJ; Xiao CW; You TG; Zheng YX; Gao W; Zhou ZQ; Chen J; Xue XB; Fan J; Zhang H
    Mol Cancer; 2012 May; 11():31. PubMed ID: 22569271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent antitumor effect of interleukin-24 gene in the survivin promoter and retinoblastoma double-regulated oncolytic adenovirus.
    Zhang KJ; Wang YG; Cao X; Zhong SY; Wei RC; Wu YM; Yue XT; Li GC; Liu XY
    Hum Gene Ther; 2009 Aug; 20(8):818-30. PubMed ID: 19320563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A hypoxia- and {alpha}-fetoprotein-dependent oncolytic adenovirus exhibits specific killing of hepatocellular carcinomas.
    Kwon OJ; Kim PH; Huyn S; Wu L; Kim M; Yun CO
    Clin Cancer Res; 2010 Dec; 16(24):6071-82. PubMed ID: 21169258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.